Treatment With Nab-paclitaxel in Cutaneous SCC
NCT02076243
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
2
Enrollment
OTHER
Sponsor class
Stopped
Closed by sponsor
Conditions
Cutaneous Squamous Cell Carcinoma
Interventions
DRUG:
nab-paclitaxel
Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
[object Object]